Profil
Peter G.
Ulrich was the founder of TargeGen, Inc. founded in 2001, where he held the titles of President & Chief Executive Officer from 2002 to 2009.
He also held former positions as Chief Executive Officer at La Jolla Pharmaceutical Co. and Medigene, Inc., and as Director at BlueWillow Biologics, Inc. Additionally, he was a Principal at Baxter Healthcare Corp.
Ulrich received his undergraduate degree from The University of Texas at Austin and his graduate degree from the University of Dallas.
Anciens postes connus de Peter G. Ulrich
| Sociétés | Poste | Fin |
|---|---|---|
BlueWillow Biologics, Inc.
BlueWillow Biologics, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Directeur/Membre du Conseil | - |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Corporate Officer/Principal | - |
MediGene, Inc.
MediGene, Inc. Pharmaceuticals: MajorHealth Technology Develops herpes simplex virus technologies for the treatment of tumors and for gene delivery | President | - |
| LA JOLLA PHARMACEUTICAL COMPANY | President | - |
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Directeur Général | - |
Formation de Peter G. Ulrich
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
BlueWillow Biologics, Inc.
BlueWillow Biologics, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Health Technology |
MediGene, Inc.
MediGene, Inc. Pharmaceuticals: MajorHealth Technology Develops herpes simplex virus technologies for the treatment of tumors and for gene delivery | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Dallas
University of Dallas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















